Eledon Pharmaceuticals Submits IND To FDA For Registrational Tegoprubart Study In Islet Cell Transplantation For Type 1 Diabetes; Reaffirms Q4 2026 Initiation Of Phase 3 LEGACY Kidney Transplant Trial

Benzinga Newsdesk www.benzinga.com Positive 80.8%

Neg 0% Neu 0% Pos 80.8%

Comments

No comments yet. Be the first!